世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
Embolotherapy Market - Global Embolotherapy Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Product Type Coverage, By Cancer Indication Coverage, By Procedure Coverage, By End User Coverage, By Geographic Coverage and By Company)
The global embolotherapy market, valued at approximately US$3.8 billion in 2023, is poised for remarkable growth, with forecasts indicating it will reach around US$6.5 billion by 2030. This growth ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global embolotherapy market, valued at approximately US$3.8 billion in 2023, is poised for remarkable growth, with forecasts indicating it will reach around US$6.5 billion by 2030. This growth trajectory is supported by a compound annual growth rate (CAGR) of 7.9% during the period from 2023 to 2030. Embolotherapy, a minimally invasive technique used to treat conditions like cancer and vascular diseases, is becoming increasingly popular due to technological advancements and the rising demand for effective treatments.Key Insights into the Embolotherapy Market 1. Rising Demand for Minimally Invasive Procedures: One of the primary drivers of the embolotherapy market is the increasing preference for minimally invasive procedures. Patients favor these treatments due to shorter recovery times and fewer complications compared to traditional surgical options. 2. Advancements in Embolic Agent Technology: Ongoing innovations in embolic agents are enhancing the precision and safety of embolization procedures. These technological breakthroughs allow for more targeted treatments with minimal side effects, driving market expansion. 3. Growing Need for Targeted Cancer Therapies: The use of embolotherapy in cancer treatment is rapidly increasing. This shift towards personalized, targeted therapies is significantly contributing to the overall growth of the embolotherapy market. 4. Expanding Applications Beyond Oncology: While embolotherapy is well-established in cancer care, its use in treating vascular diseases is on the rise, opening up new avenues for the market’s growth. 5. Embolic Agents Dominating the Market: Embolic agents are expected to hold the largest market share in 2023, driven by their crucial role in blocking blood flow during medical procedures. 6. Transcatheter Arterial Embolization (TAE) Leading Procedures: TAE is projected to account for the largest share of therapeutic procedures in 2023, due to its widespread use in treating conditions such as tumors and vascular abnormalities. 7. Hospitals and Clinics as Leading End Users: Hospitals and clinics are set to dominate the end-user segment due to their advanced infrastructure and specialized expertise in performing embolotherapy procedures. 8. North America Leading Regional Growth: North America is expected to account for the largest share of the global embolotherapy market. The region's advanced healthcare system, high prevalence of vascular diseases, and swift adoption of new technologies contribute to its dominance. 9. Asia Pacific Witnessing Rapid Expansion: The Asia Pacific region is anticipated to experience the fastest growth in the embolotherapy market, driven by improving healthcare infrastructure, increased awareness of minimally invasive procedures, and a growing incidence of cardiovascular diseases. Market Overview: Past, Present, and Future The embolotherapy market has seen considerable growth in recent years, largely due to the increasing demand for minimally invasive treatments and technological advancements in embolic agents. The shift from traditional surgery to less invasive procedures has played a key role in shaping the market. Over time, embolotherapy has gained traction across various medical fields due to its effectiveness and safety. Looking forward, the market is expected to maintain its growth momentum. Continued innovations in embolic materials and a broader understanding of the benefits of embolotherapy will drive further adoption. As healthcare systems prioritize cost-effective and patient-friendly treatments, embolotherapy is positioned to become a crucial component of interventional medicine. Key Drivers of Market Growth 1. Technological Innovations in Embolic Agents: The development of advanced embolic agents, such as biocompatible polymers and microspheres, is improving the precision and effectiveness of embolization procedures. These innovations reduce the risk of unintended damage and improve patient outcomes. 2. Rising Prevalence of Vascular Diseases: The growing incidence of vascular conditions, including tumors, aneurysms, and malformations, is a major factor driving the demand for embolotherapy. As global populations age and lifestyle-related health issues increase, the need for minimally invasive treatments like embolotherapy is expected to grow. 3. Demand for Less Invasive Treatment Options: Patients are increasingly opting for minimally invasive procedures that offer shorter recovery times, fewer complications, and reduced hospital stays. Embolotherapy’s minimally invasive nature aligns with these preferences, further fueling its adoption across various medical fields. Major Challenges Facing the Market 1. Lack of Awareness and Training: A significant challenge to market growth is the limited awareness and specialized training among healthcare providers regarding embolotherapy techniques. The complexity of these procedures requires specialized knowledge, and the lack of widespread training programs could hinder broader adoption. 2. Regulatory and Reimbursement Challenges: Strict regulatory approval processes and inconsistent reimbursement policies across different regions can slow the adoption of new embolotherapy technologies, limiting market growth. Emerging Trends and Opportunities 1. AI and VR Integration: The use of artificial intelligence (AI) and virtual reality (VR) in embolotherapy is transforming diagnosis, treatment planning, and monitoring. Companies like Siemens Healthineers and GE Healthcare are investing in AI-driven solutions to enhance the precision of procedures, ultimately improving patient outcomes. 2. Increased Use in Neurointerventions: The application of embolotherapy in neurointerventional procedures is gaining momentum, particularly in regions like North America and the Asia Pacific. Companies such as Medtronic and Stryker are developing specialized devices for neuroembolization, meeting the growing demand for minimally invasive neurological treatments. 3. Growth in Outpatient Procedures: Technological advancements are enabling more embolotherapy procedures to be performed in outpatient settings, offering greater convenience for patients. Companies like Boston Scientific and Terumo Corporation are developing devices tailored for outpatient use, contributing to this emerging trend. Regulatory Analysis The embolotherapy market operates within a strict regulatory framework aimed at ensuring the safety and efficacy of embolic agents and related products. In the United States, the Food and Drug Administration (FDA) oversees the regulation of these products under the Medical Device Regulation Act. Compliance with FDA guidelines is essential for market entry and product development. In the European Union, the CE Marking process, supervised by the European Medicines Agency (EMA), ensures that products adhere to stringent safety and performance standards. Recent regulatory changes, such as the Medical Devices Regulation (MDR) in the EU, have imposed additional scrutiny on products, requiring companies to adapt to new requirements to maintain market access. Competitive Analysis Technological innovation and strategic partnerships are expected to shape the competitive Analysis of the embolotherapy market. Companies investing in AI-driven solutions and other advanced technologies are likely to gain a competitive advantage. Additionally, forming strategic partnerships along the supply chain will be critical for ensuring access to raw materials and optimizing distribution channels. Leading Companies in the Embolotherapy Market 1. Medtronic Plc. 2. Stryker Corporation 3. Johnson & Johnson 4. BTG Plc. 5. Cook Medical 6. Penumbra Inc. 7. Abbott Laboratories 8. Boston Scientific Corporation 9. Merit Medical Systems 10. Terumo Corporation Global Embolotherapy Market Segmentation • By Product Type: o Embolic Agents (Microspheres, Embolic coils, Embolic Plug Systems, Detachable Balloons, Liquid Embolic Agents, others) o Support Devices (Microcatheters, Guidewires) • By Indication: o Cancer o Peripheral Vascular Disease o Urological & Nephrological Disorder o Gastrointestinal Disorder o others • By Procedure: o Transcatheter Arterial Embolization (TAE) o Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) o Transarterial Chemoembolization (TACE) • By End User: o Hospitals & Clinics o Ambulatory Surgical Centers o Others • By Geographic Region: o North America (U.S., Canada) o Europe (Germany, U.K., France, Italy, Turkey, Russia, Rest of Europe) o Asia Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia Pacific) o Latin America (Brazil, Mexico, Argentina, Rest of Latin America) o Middle East & Africa (GCC, South Africa, Egypt, Nigeria, Rest of Middle East & Africa) Table of Contents1. Executive Summary1.1. Global Embolotherapy Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2022 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. Covid-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Embolotherapy Market Outlook, 2018 - 2030 3.1. Global Embolotherapy Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030 3.1.1. Key Highlights 3.1.1.1. Embolic Agents 3.1.1.1.1. Microspheres 3.1.1.1.2. Embolic coils 3.1.1.1.3. Embolic Plug Systems 3.1.1.1.4. Detachable Ballons 3.1.1.1.5. Liquid Embolic Agents, 3.1.1.1.6. others 3.1.1.2. Support Devices 3.1.1.3. Microcatheters 3.1.1.4. Guidewires 3.2. Global Embolotherapy Market Outlook, by Disease Indication, Value (US$ Mn), 2018 - 2030 3.2.1. Key Highlights 3.2.1.1. Cancer 3.2.1.2. Peripheral Vascular Disease 3.2.1.3. Peripheral Vascular Disease 3.2.1.4. Urological & Nephrological Disorder 3.2.1.5. Gastrointestinal Disorder 3.2.1.6. others 3.3. Global Embolotherapy Market Outlook, by Procedure, Value (US$ Mn), 2018 - 2030 3.3.1. Key Highlights 3.3.1.1. Transcatheter Arterial Embolization (TAE) 3.3.1.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) 3.3.1.3. Transarterial Chemoembolization (TACE) 3.4. Global Embolotherapy Market Outlook, by End User, Value (US$ Mn), 2018 - 2030 3.4.1. Key Highlights Snacks 3.4.1.1. Hospitals& Clinics 3.4.1.2. Ambulatory Surgical Centre 3.4.1.3. Others 3.5. Global Embolotherapy Market Outlook, by Region, Value (US$ Mn), 2018 - 2030 3.5.1. Key Highlights 3.5.1.1. North America 3.5.1.2. Europe 3.5.1.3. Asia Pacific 3.5.1.4. Latin America 3.5.1.5. Middle East & Africa 4. North America Embolotherapy Market Outlook, 2018 - 2030 4.1. North America Embolotherapy Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030 4.1.1. Key Highlights 4.1.1.1. Embolic Agents 4.1.1.1.1. Microspheres 4.1.1.1.2. Embolic coils 4.1.1.1.3. Embolic Plug Systems 4.1.1.1.4. Detachable Ballons 4.1.1.1.5. Liquid Embolic Agents, 4.1.1.1.6. others 4.1.1.2. Support Devices 4.1.1.3. Microcatheters 4.1.1.4. Guidewires 4.2. North America Embolotherapy Market Outlook, by Disease Indication, Value (US$ Mn), 2018 - 2030 4.2.1. Key Highlights 4.2.1.1. Infants 4.2.1.2. Children 4.2.1.3. Adolscents / Young Adults 4.2.1.4. Adults 4.3. North America Embolotherapy Market Outlook, by Procedure, Value (US$ Mn), 2018 - 2030 4.3.1. Key Highlights 4.3.1.1. Transcatheter Arterial Embolization (TAE) 4.3.1.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) 4.3.1.3. Transarterial Chemoembolization (TACE) 4.4. North America Embolotherapy Market Outlook, by End User, Value (US$ Mn), 2018 - 2030 4.4.1. Key Highlights 4.4.1.1. Hospitals& Clinics 4.4.1.2. Ambulatory Surgical Centre 4.4.1.3. Others 4.4.2. BPS Analysis/Market Attractiveness Analysis 4.5. North America Embolotherapy Market Outlook, by Country, Value (US$ Mn), 2018 - 2030 4.5.1. Key Highlights 4.5.1.1. U.S. Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 4.5.1.2. U.S. Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 4.5.1.3. U.S. Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 4.5.1.4. U.S. Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 4.5.1.5. Canada Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 4.5.1.6. Canada Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 4.5.1.7. Canada Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 4.5.1.8. Canada Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 4.5.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Embolotherapy Market Outlook, 2018 - 2030 5.1. Europe Embolotherapy Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030 5.1.1. Key Highlights 5.1.1.1. Embolic Agents 5.1.1.1.1. Microspheres 5.1.1.1.2. Embolic coils 5.1.1.1.3. Embolic Plug Systems 5.1.1.1.4. Detachable Ballons 5.1.1.1.5. Liquid Embolic Agents, 5.1.1.1.6. others 5.1.1.2. Support Devices 5.1.1.3. Microcatheters 5.1.1.4. Guidewires 5.2. Europe Embolotherapy Market Outlook, by Disease Indication, Value (US$ Mn), 2018 - 2030 5.2.1. Key Highlights 5.2.1.1. Cancer 5.2.1.2. Peripheral Vascular Disease 5.2.1.3. Peripheral Vascular Disease 5.2.1.4. Urological & Nephrological Disorder 5.2.1.5. Gastrointestinal Disorder 5.2.1.6. others 5.3. Europe Embolotherapy Market Outlook, by Procedure, Value (US$ Mn), 2018 - 2030 5.3.1. Key Highlights 5.3.1.1. Transcatheter Arterial Embolization (TAE) 5.3.1.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) 5.3.1.3. Transarterial Chemoembolization (TACE) 5.4. Europe Embolotherapy Market Outlook, by End User, Value (US$ Mn), 2018 - 2030 5.4.1. Key Highlights 5.4.1.1. Hospitals& Clinics 5.4.1.2. Ambulatory Surgical Centre 5.4.1.3. Others 5.4.2. BPS Analysis/Market Attractiveness Analysis 5.5. Europe Embolotherapy Market Outlook, by Country, Value (US$ Mn), 2018 - 2030 5.5.1. Key Highlights 5.5.1.1. Germany Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 5.5.1.2. Germany Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 5.5.1.3. Germany Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 5.5.1.4. Germany Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 5.5.1.5. U.K. Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 5.5.1.6. U.K. Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 5.5.1.7. U.K. Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 5.5.1.8. U.K. Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 5.5.1.9. France Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 5.5.1.10. France Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 5.5.1.11. France Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 5.5.1.12. France Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 5.5.1.13. Italy Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 5.5.1.14. Italy Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 5.5.1.15. Italy Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 5.5.1.16. Italy Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 5.5.1.17. Turkey Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 5.5.1.18. Turkey Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 5.5.1.19. Turkey Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 5.5.1.20. Turkey Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 5.5.1.21. Russia Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 5.5.1.22. Russia Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 5.5.1.23. Russia Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 5.5.1.24. Russia Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 5.5.1.25. Rest of Europe Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 5.5.1.26. Rest of Europe Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 5.5.1.27. Rest of Europe Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 5.5.1.28. Rest of Europe Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 5.5.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Embolotherapy Market Outlook, 2018 - 2030 6.1. Asia Pacific Embolotherapy Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030 6.1.1. Key Highlights 6.1.1.1. Embolic Agents 6.1.1.1.1. Microspheres 6.1.1.1.2. Embolic coils 6.1.1.1.3. Embolic Plug Systems 6.1.1.1.4. Detachable Ballons 6.1.1.1.5. Liquid Embolic Agents, 6.1.1.1.6. others 6.1.1.2. Support Devices 6.1.1.3. Microcatheters 6.1.1.4. Guidewires 6.2. Asia Pacific Embolotherapy Market Outlook, by Disease Indication, Value (US$ Mn), 2018 - 2030 6.2.1. Key Highlights 6.2.1.1. Cancer 6.2.1.2. Peripheral Vascular Disease 6.2.1.3. Peripheral Vascular Disease 6.2.1.4. Urological & Nephrological Disorder 6.2.1.5. Gastrointestinal Disorder 6.2.1.6. others 6.3. Asia Pacific Embolotherapy Market Outlook, by Procedure, Value (US$ Mn), 2018 - 2030 6.3.1. Key Highlights 6.3.1.1. Transcatheter Arterial Embolization (TAE) 6.3.1.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) 6.3.1.3. Transarterial Chemoembolization (TACE) 6.4. Asia Pacific Embolotherapy Market Outlook, by End User, Value (US$ Mn), 2018 - 2030 6.4.1. Key Highlights 6.4.1.1. Hospitals& Clinics 6.4.1.2. Ambulatory Surgical Centre 6.4.1.3. Others 6.4.2. BPS Analysis/Market Attractiveness Analysis 6.5. Asia Pacific Embolotherapy Market Outlook, by Country, Value (US$ Mn), 2018 - 2030 6.5.1. Key Highlights 6.5.1.1. China Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 6.5.1.2. China Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 6.5.1.3. China Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 6.5.1.4. China Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 6.5.1.5. Japan Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 6.5.1.6. Japan Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 6.5.1.7. Japan Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 6.5.1.8. Japan Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 6.5.1.9. South Korea Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 6.5.1.10. South Korea Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 6.5.1.11. South Korea Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 6.5.1.12. South Korea Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 6.5.1.13. India Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 6.5.1.14. India Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 6.5.1.15. India Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 6.5.1.16. India Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 6.5.1.17. Southeast Asia Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 6.5.1.18. Southeast Asia Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 6.5.1.19. Southeast Asia Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 6.5.1.20. Southeast Asia Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 6.5.1.21. Rest of Asia Pacific Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 6.5.1.22. Rest of Asia Pacific Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 6.5.1.23. Rest of Asia Pacific Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 6.5.1.24. Rest of Asia Pacific Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 6.5.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Embolotherapy Market Outlook, 2018 - 2030 7.1. Latin America Embolotherapy Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030 7.1.1. Key Highlights 7.1.1.1. Embolic Agents 7.1.1.1.1. Microspheres 7.1.1.1.2. Embolic coils 7.1.1.1.3. Embolic Plug Systems 7.1.1.1.4. Detachable Ballons 7.1.1.1.5. Liquid Embolic Agents, 7.1.1.1.6. others 7.1.1.2. Support Devices 7.1.1.3. Microcatheters 7.1.1.4. Guidewires 7.2. Latin America Embolotherapy Market Outlook, by Disease Indication, Value (US$ Mn), 2018 - 2030 7.2.1. Key Highlights 7.2.1.1. Cancer 7.2.1.2. Peripheral Vascular Disease 7.2.1.3. Peripheral Vascular Disease 7.2.1.4. Urological & Nephrological Disorder 7.2.1.5. Gastrointestinal Disorder 7.2.1.6. others 7.3. Latin America Embolotherapy Market Outlook, by Procedure, Value (US$ Mn), 2018 - 2030 7.3.1. Key Highlights 7.3.1.1. Transcatheter Arterial Embolization (TAE) 7.3.1.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) 7.3.1.3. Transarterial Chemoembolization (TACE) 7.4. Latin America Embolotherapy Market Outlook, by End User, Value (US$ Mn), 2018 - 2030 7.4.1. Key Highlights 7.4.1.1. Hospitals& Clinics 7.4.1.2. Ambulatory Surgical Centre 7.4.1.3. Others 7.4.2. BPS Analysis/Market Attractiveness Analysis 7.5. Latin America Embolotherapy Market Outlook, by Country, Value (US$ Mn), 2018 - 2030 7.5.1. Key Highlights 7.5.1.1. Brazil Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 7.5.1.2. Brazil Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 7.5.1.3. Brazil Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 7.5.1.4. Brazil Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 7.5.1.5. Mexico Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 7.5.1.6. Mexico Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 7.5.1.7. Mexico Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 7.5.1.8. Mexico Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 7.5.1.9. Argentina Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 7.5.1.10. Argentina Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 7.5.1.11. Argentina Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 7.5.1.12. Argentina Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 7.5.1.13. Rest of Latin America Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 7.5.1.14. Rest of Latin America Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 7.5.1.15. Rest of Latin America Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 7.5.1.16. Rest of Latin America Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 7.5.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Embolotherapy Market Outlook, 2018 - 2030 8.1. Middle East & Africa Embolotherapy Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030 8.1.1. Key Highlights 8.1.1.1. Embolic Agents 8.1.1.1.1. Microspheres 8.1.1.1.2. Embolic coils 8.1.1.1.3. Embolic Plug Systems 8.1.1.1.4. Detachable Ballons 8.1.1.1.5. Liquid Embolic Agents, 8.1.1.1.6. others 8.1.1.2. Support Devices 8.1.1.3. Microcatheters 8.1.1.4. Guidewires 8.2. Middle East & Africa Embolotherapy Market Outlook, by Disease Indication, Value (US$ Mn), 2018 - 2030 8.2.1. Key Highlights 8.2.1.1. Cancer 8.2.1.2. Peripheral Vascular Disease 8.2.1.3. Peripheral Vascular Disease 8.2.1.4. Urological & Nephrological Disorder 8.2.1.5. Gastrointestinal Disorder 8.2.1.6. others 8.3. Middle East & Africa Embolotherapy Market Outlook, by Procedure, Value (US$ Mn), 2018 - 2030 8.3.1. Key Highlights 8.3.1.1. Transcatheter Arterial Embolization (TAE) 8.3.1.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) 8.3.1.3. Transarterial Chemoembolization (TACE) 8.4. Middle East & Africa Embolotherapy Market Outlook, by End User, Value (US$ Mn), 2018 - 2030 8.4.1. Key Highlights 8.4.1.1. Hospitals& Clinics 8.4.1.2. Ambulatory Surgical Centre 8.4.1.3. Others 8.4.2. BPS Analysis/Market Attractiveness Analysis 8.5. Middle East & Africa Embolotherapy Market Outlook, by Country, Value (US$ Mn), 2018 - 2030 8.5.1. Key Highlights 8.5.1.1. GCC Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 8.5.1.2. GCC Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 8.5.1.3. GCC Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 8.5.1.4. GCC Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 8.5.1.5. South Africa Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 8.5.1.6. South Africa Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 8.5.1.7. South Africa Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 8.5.1.8. South Africa Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 8.5.1.9. Egypt Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 8.5.1.10. Egypt Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 8.5.1.11. Egypt Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 8.5.1.12. Egypt Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 8.5.1.13. Nigeria Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 8.5.1.14. Nigeria Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 8.5.1.15. Nigeria Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 8.5.1.16. Nigeria Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 8.5.1.17. Rest of Middle East & Africa Embolotherapy Market by Product Type, Value (US$ Mn), 2018 - 2030 8.5.1.18. Rest of Middle East & Africa Embolotherapy Market Disease Indication, Value (US$ Mn), 2018 - 2030 8.5.1.19. Rest of Middle East & Africa Embolotherapy Market Procedure, Value (US$ Mn), 2018 - 2030 8.5.1.20. Rest of Middle East & Africa Embolotherapy Market End User, Value (US$ Mn), 2018 - 2030 8.5.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Procedure vs Application Heatmap 9.2. Manufacturer vs Application Heatmap 9.3. Company Market Share Analysis, 2022 9.4. Competitive Dashboard 9.5. Company Profiles 9.5.1. Medtronic Plc. 9.5.1.1. Company Overview 9.5.1.2. Product Portfolio 9.5.1.3. Financial Overview 9.5.1.4. Business Strategies and Development 9.5.2. Stryker Corporation 9.5.2.1. Company Overview 9.5.2.2. Product Portfolio 9.5.2.3. Financial Overview 9.5.2.4. Business Strategies and Development 9.5.3. Johnson & Johnson 9.5.3.1. Company Overview 9.5.3.2. Product Portfolio 9.5.3.3. Financial Overview 9.5.3.4. Business Strategies and Development 9.5.4. BTG Plc. 9.5.4.1. Company Overview 9.5.4.2. Product Portfolio 9.5.4.3. Financial Overview 9.5.4.4. Business Strategies and Development 9.5.5. Cook Medical 9.5.5.1. Company Overview 9.5.5.2. Product Portfolio 9.5.5.3. Financial Overview 9.5.5.4. Business Strategies and Development 9.5.6. Penumbra Inc. 9.5.6.1. Company Overview 9.5.6.2. Product Portfolio 9.5.6.3. Financial Overview 9.5.6.4. Business Strategies and Development 9.5.7. Abbott Laboratories 9.5.7.1. Company Overview 9.5.7.2. Product Portfolio 9.5.7.3. Financial Overview 9.5.7.4. Business Strategies and Development 9.5.8. Boston Scientific Corporation 9.5.8.1. Company Overview 9.5.8.2. Product Portfolio 9.5.8.3. Business Strategies and Development 9.5.9. Merit Medical Systems 9.5.9.1. Company Overview 9.5.9.2. Product Portfolio 9.5.9.3. Financial Overview 9.5.9.4. Business Strategies and Development 9.5.10. Terumo Corporation 9.5.10.1. Company Overview 9.5.10.2. Product Portfolio 9.5.10.3. Financial Overview 9.5.10.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（その他）の最新刊レポートFairfield Market Research 社の最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/24 10:26 144.74 円 161.12 円 195.86 円 |
